1. Alleviation of AF related symptoms following acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm with flecainide acetate oral inhalation solution. (3rd October 2022) Authors: Camm, A J; Crijns, H J G M; Elvan, A; Tuininga, Y; Badings, E; Kuijper, A F M; De Jong, J S S G; Lee, M; Schellings, D; Van Gelder, I C; Ruskin, J; Kowey, P; Dufton, C; Maupas, J; Belardinelli, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictors of successful cardioversion of recent-onset atrial fibrillation to sinus rhythm with orally inhaled flecainide. (3rd October 2022) Authors: Ruskin, J; Dufton, C; Maupas, J; Crijns, H; Elvan, A; De Jong, J; Oosterhof, T; Tuininga, Y; Badings, E; Aksoy, I; Nuyens, D; Van Dijk, V; Camm, A J; Kowey, P; Belardinelli, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the Famous Triage study. (14th October 2021) Authors: Tolsma, R T; Fokkert, M J; Van Dongen, D N; Slingerland, R J; Badings, E; Van Der Sluis, A; Ottervanger, J P; Van 'T Hof, A W J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗